Biggest News Aggregation in the World
📰 Medication Guide News

Page 11 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn's Disease Meets All Primary and Secondary Endpoints

SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active Crohns...
Laurent Peyrin Biroulet Roopal Thakkar European Medicines Agency Crohn Colitis Foundation Of America Abbvie Inc University Hospital Of Nancy

Sotyktu (deucravacitinib) Long-Term Data Demonstrate Durable Efficacy and Consistent Safety for up t

Clinical response was maintained at 73.2% for Psoriasis Area and Severity Index (PASI) 75 with three years of continuous Sotyktu treatment in the POETYK PSO long-term extension trialSotyktu demonstrated a consistent safety profile with no increases in adverse events or serious adverse events and no emergence of any...
United States April Armstrong Bristol Myers Squibb Los Angeles Roland Chen Exchange Commission

New Long-Term Data from Incyte Phase 3 TRuE-V Program Demonstrates Efficacy of Continued Treatment with Opzelura® (Ruxolitinib) Cream in Nonsegmental Vitiligo Patients

- Patients who initially experienced limited or no facial or total body repigmentation at six months achieved improved repigmentation after continued treatment with Opzelura for up to two years -...
United States Noord Holland Jim Lee Albert Wolkerstorfer European Academy Of Dermatology Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science